期刊文献+

血浆BNP联合cTnT和D-二聚体预测PCI术后近期不良预后的效能探讨 被引量:1

Predictive effect of plasma brain natriuretic peptide combined with cTnT and D-Dimer on short-term adverse prognosis after PCI
原文传递
导出
摘要 目的:观察血浆BNP联合cTnT、D-二聚体在预测PCI术后近期不良预后的效能。方法:以152例因急性ST段抬高型心肌梗死接受PCI治疗的病例为研究对象。记录PCI术后近期(3个月)不良预后情况,分析预后不良者与预后良好者的基线资料及血浆病情相关指标差异,采用多因素回归分析法分析预后不良的影响因素,以ROC曲线图进行指标临床预后预测效能分析。结果:152例PCI患者术后3月预后不良率为17.11%(26例),预后不良者与预后良好者在血压(收缩压、舒张压)、是否吸烟、血浆病情相关指标(cTnT、D-二聚体、BNP)上比较(P<0.05)。BNP、cTnT、D-二聚体均是PCI术后近期预后不良的危险因素(OR=2.156,1.522,1.565;均P<0.05)。ROC曲线分析显示:BNP、cTnT、D-二聚体三者联合预测不良预后的敏感度(92.74%)、特异度(90.73%)、准确性(89.78%)均优于单纯BNP(75.63%、74.48%、69.83%)、单纯cTnT(72.12%、74.38%、70.79%)、单纯D-二聚体(72.12%、74.38%、70.79%)(P<0.05)。结论:血清cTn、BNP、D-二聚体水平均可对PCI术的近期不良预后产生影响,相比与单纯BNP、单纯cTnT、单纯D-二聚体,三者联合的PCI术后近期不良预后的预测效能更佳。 Objective:To observe the effect of plasma BNP combined with cTnT and D-Dimer in predicting the short-term adverse prognosis after PCI.Method:A total of 152 patients with ST-segment elevation myocardial infarction(ST-segment elevation myocardial infarction)were treated with PCI(time range:2018.1-2018.12).The short-term(3 months)adverse prognosis after PCI was recorded,and the baseline data and plasma disease-related indicators of patients with poor prognosis and good prognosis were analyzed.Multivariate regression analysis was used to analyze the influencing factors of poor prognosis,and ROC curve was used to analyze the predictive efficacy of clinical prognosis.Result:The poor prognosis rate of 152 patients with PCI was 17.11%(26 cases)in 3 months after operation.The poor prognosis patients were compared with those with good prognosis in blood pressure(systolic blood pressure,diastolic blood pressure),smoking or not,plasma disease-related indicators(cTnT,D-Dimer,BNP)(P<0.05).BNP,cTnT and D-Dimer were risk factors for poor prognosis after PCI(OR=2.156,1.522,1.565;P<0.05).ROC curve analysis showed that the sensitivity(92.74%),specificity(90.73%)and accuracy(89.78%)of BNP,cTnT and D-Dimer were better than those of BNP alone(75.63%,74.48%,69.83%),cTnT alone(72.12%,74.38%,70.79%)and D-Dimer alone(72.12%,74.38%,70.79%)(P<0.05).Conclusion:Serum levels of cTn,BNP and D-Dimer can affect the short-term adverse prognosis of PCI.Compared with BNP,cTnT and D-Dimer alone,the combination of them has better predictive effect on the short-term adverse prognosis of PCI.
作者 高念城 钱文浩 周浩 GAO Niancheng;QIAN Wenhao;ZHOU Hao(Department of Cardiology,the Affiliated Suqian Hospital of Xuzhou Medical University,Suqian,Jiangsu,223800,China;Department of Cardiology,Affiliated Hospital of Xuzhou Medical University)
出处 《临床急诊杂志》 CAS 2020年第7期558-562,共5页 Journal of Clinical Emergency
关键词 脑钠肽 D-二聚体 心肌肌钙蛋白T 经皮冠状动脉介入治疗 不良预后 预测效能 brain natriuretic peptide D-Dimer cTnT percutaneous coronary intervention adverse prognosis predictive efficacy
  • 相关文献

参考文献15

二级参考文献122

  • 1Sabine Vecchio,Elisabetta Varani,Tania Chechi,Marco Balducelli,Giuseppe Vecchi,Matteo Aquilina,Giulia Ricci Lucchi,Alessro Dal Monte,Massimo Margheri.Coronary thrombus in patients undergoing primary PCI for STEMI:Prognostic significance and management[J].World Journal of Cardiology,2014,6(6):381-392. 被引量:18
  • 2魏勇,刘少稳,周根青,齐保振,陈松文,陈铮,欧阳平,费民忠.老年急性心肌梗死患者的血脂异常特点[J].中国老年学杂志,2014,34(9):2411-2414. 被引量:4
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 4Claessen B E, Dangas G D, Weisz G, et al. Prognostic impact of a chronk total occlusion in a non-infarct-related artery in patients with ST-seg- ment elevation myocardial infarction: 3 year results from the HORI- ZONS-AMI trial[J]. Eur Heart J, 2012,33 (6) : 768-- 775.
  • 5Mylotte D, Moriee M C, El tchaninoff H, et al. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest,and cardiogenic shock:the role of prima- ry muitivessel revascularization[J ]. J ACC Cardiovasc Interv, 2013, 6(2):115--125.
  • 6Levine G N, Bates E R, Blankenship J C, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the Ameri- can College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiogra- phy and Interventions[J]. Circulation, 2011,124 : e514-- e651.
  • 7Kornowski R, Mehran R, Dangas G, et al. Prognostic impact of staged versus "onetime" multivessel percutaneous intervention in acute myo- cardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarc tion) trial[J]. J Am Coll Cardiol, 2011,58 (7) : 704-- 711.
  • 8Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel cor- onary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies[J]. J Am Coll Cardiol, 2013,62 (16) : 1421 -- 1431.
  • 9Mehta R H,Kanl P,Lopes R D,ev al. Variations in practice and outcomes in patients undergoing primary percutaneous coronary in tervention in the United States and Canada: insights from the As- sessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial[J]. Am Heart J,2012,163(5) :797--803.
  • 10Minutello R M,Chou E T, Hong M K,et al. Impact of race and eth- nicity on inhospital outcomes after percutaneous coronary interven- tion (report from the 2000- 2001 New York State Angioplasty Registry)[ J]. Am Heart J,2006,151(1) :164--167.

共引文献2057

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部